Biomarker screening using integrated bioinformatics for the development of "normal—impaired glucose intolerance—type 2 diabetes mellitus".

MLA

Luo, Dongqiang, et al. “Biomarker Screening Using Integrated Bioinformatics for the Development of ‘Normal—impaired Glucose Intolerance—type 2 Diabetes Mellitus.’” Scientific Reports, vol. 14, no. 1, Feb. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41598-024-55199-y.

APA

Luo, D., Gao, X., Zhu, X., Xu, J., Gao, P., Zou, J., Fan, Q., Xu, Y., & Liu, T. (2024). Biomarker screening using integrated bioinformatics for the development of “normal—impaired glucose intolerance—type 2 diabetes mellitus.” Scientific Reports, 14(1), 1–13. https://doi.org/10.1038/s41598-024-55199-y

Chicago

Luo, Dongqiang, Xiaolu Gao, Xianqiong Zhu, Jiongbo Xu, Pengfei Gao, Jiayi Zou, Qiaoming Fan, Ying Xu, and Tian Liu. 2024. “Biomarker Screening Using Integrated Bioinformatics for the Development of ‘Normal—impaired Glucose Intolerance—type 2 Diabetes Mellitus.’” Scientific Reports 14 (1): 1–13. doi:10.1038/s41598-024-55199-y.